Clinical Trial Protocol for the Apa/Enza-short Study: A Randomized Nationwide Study of Shortened 12-Month Duration of Androgen Receptor Signaling Agent in Combination With Androgen Deprivation Therapy in Patients With Metastatic Low-volume Castration-sensitive Prostate Cancer

European Urology Focus 2026 Open access

Read full text

Authors: Mahtab Hamidikia, Tanja C. van Dijk, John W.M. Martens, Khrystany T. Isebia, Ronald de Wit, Nick Beije

DOI: 10.1016/j.euf.2026.03.002

Cited by: 0

References: 12

Fields of Study & Subjects

Prostate Cancer Treatment and Research Prostate Cancer Diagnosis and Treatment Advanced Breast Cancer Therapies

References 12